
Scientific collaborations
Active participation as SME partner in scientific projects is one of the core activities of Hycult Biotech’s R&D department. Our projects range from one-to-one collaborations to international consortia. We add value in research projects and consortia by combining strength of our scientific focus, industrial development skills as well as commercial experience.
Latest Hycult Biotech news
- Discover Cross-Reactive Complement ELISA for NHP ResearchBridging Human and NHP Complement Research. At Hycult Biotech, we understand the importance of testing therapeutic agents on non-human primates (NHP) samples in order to get approval to enter clinical phases. That is why we have committed to the following initiative: Testing our existing complement ELISA assays for NHP research. Why Non Human Primate Samples… Read more: Discover Cross-Reactive Complement ELISA for NHP Research
- New Human Complement Pathway AssaysWe are very proud of our newly developed human classical and alternative complement pathway assays. They are produced in response to a growing demand for quantitative investigation of complement inhibitors or regulators at lower sample dilutions. This development aims to address the issue of false negative results, enabling more accurate and reliable analysis of complement… Read more: New Human Complement Pathway Assays
- Navigating the pitfalls in complement analysisOur colleague Erik Toonen shared his experience on how to analyze complement at the Complement-based Drug Development Summit in Boston in September 11-13th, 2023. He showed valuable insights on analyzing complements. For accurate complement analysis, it is important that not only the correct technique is used but also that pre-analytical sample handling is performed in… Read more: Navigating the pitfalls in complement analysis
Project | Goal | Product pipeline | More information |
HDM-FUN (H2020) | Host-Directed Medicine in invasive FUNgal infections | Biomarker panel assay for diagnosis of fungal infections | https://www.hdm-fun.eu/ |
CORVOS (MSC-ITN) | COmplement Regulation and Variations in Opportunistic infectionS | Development of antibodies and assays for measuring complement activation in infectious diseases | https://www.corvos.eu/content/home/ |
DISCOvERIE (H2020) | Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe | Biomarker panel assays for diagnosis of IBS / research tools for animal models | https://discoverie.eu/ |
STRIDE-COM (LSH-TKI) | Improved risk stratification prior to Kidney Transplantation by Discriminating Pathogenic from Clinically Irrelevant Donor Epitope Specific HLA antibodies in relation to complement activation | Biomarker panel assay for prediction of kidney rejection | |
SCIFIMED | Screening of inFlammation to enable personalized Medicine | Aim to develop a multiplex detection system to simultaneously quantify and analyse the functional activity of all seven FH-protein family members | https://www.scifimed.eu/ |
NWO-NACTAR (NWO-TTW) | Novel Antibacterial Compounds and Therapies Antagonizing Resistance – Boosting host immunity against Klebsiella pneumoniae via therapeutic antibodies | Research tools / functional assays for assessing complement activation | |
Dual biomarker (LSH-TKI) | Towards a dual-biomarker blood test for the diagnosis of intestinal ischemia patients | Biomarker panel for investigation of gut integrity | |
Immune Fitness (TKI AGRI & FOOD) | Identification of markers for immune-fitness and nutrients that are able to keep the immune system healthy during aging | Identification and validation of biomarkers for immune fitness | |
ENLIGHT-TEN+ | Identification of microenvironmental factors shaping the functional properties of tissue resident T cells in autoimmune diseases | Training/workshos in assay development and exploitation of research results | |
RELENT (H2020) | RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities | PR3 (cat# HK384) A1AT ELISA (cat# HK387) Cathepsin G / NE-A1AT (under development) | https://www.relent.eu |
Health-i-care (INTERREG) | Innovations for safer Healthcare – To protect the public from infections and help combat antibiotic resistance. | EcHECk assay for the detection of EHEC O157 infections (cat.# HK508) | https://www.health-i-care.eu/ |